The inaugural Festival of Biologics USA is landing in San Diego on March 4th -5th 2019 (pre-conference day on March 3rd), and we want to make sure you know everything there is to know about this brand-new event.
The Festival of Biologics USA will be combining three high-level commercial events: The Americas Antibody Congress, The Word Immunotherapy Congress, and Clinical Trials USA, under one roof, with 200+ speakers, 600+ attendees and 60+ sponsors and exhibitors.
On April 20th, 2018, Tanya Verstak interviewed Guy Iannuzzi regarding his company Mentus and the development of biotechnology in San Diego as well as Biocom. About the interviee: Guy and Mentus market entrepreneurial and technology based companies and products. Their success is enabled by creative solutions driven by customer-centric strategic Read more
Interview and article by Tatsiana “Tanya” Verstak This interview is part of our new series where we interview notable clinical researchers, others in the field, and companies about innovative new services. We begin today with Elizabeth Weeks-Rowe from San Diego. Ms. Weeks-Rowe has 17 years of research experience, including work as Read more
Elizabeth Weeks-Rowe, LVN, CCRA, a San Diego-based clinical research trainer and writer, is interviewed by Dan Sfera (“the clinical trials guru”) about her perceptions and experience in clinical research over the past 17 years. Ms. Weeks-Rowe is also the author of the novel, “Clinical Research Trials and Triumphs: A Heart Warming Novel Following a Nurse’s Journey Into Clinical Research.”
San Diego Clinical Research Network (SDCRN) is organizing a program on “Top 10 life science trends to watch in 2018” for the first week in March, and we are looking for a venue and a sponsor for this program. Would you like to host this program at your workplace? Contact teresa@clinicalresearchcurrents.com for more information.
Shanghai Pharma, a multi-billion dollar Chinese pharma conglomerate, is hunting for American corporations and research institutes it can partner with, and plans to open an R&D center in San Diego this year. This is the latest in a string of Chinese investments into San Diego’s biotech hub. (ENDPOINTS NEWS)
Shares of Intercept Pharmaceuticals (ICPT) jumped after the drug maker announced it was changing an ongoing late-stage clinical trial for a drug that treats liver disease. Patient enrollment in the study has been too slow, so Intercept has changed protocols, drastically cutting the number of patients to be enrolled and lowering the bar for clinical success. Intercept said the changes were based on discussions with the FDA. (Barrons)
by Marie Jung The announcement of the merging of two non-profit research organizations called Calibr and TSRI sparked excitement in the field of medical research on October 20th, 2016. Dr. Peter Shultz*, the leader of both institutions, shared this insight on the new formation: “The affiliation between TSRI and Calibr Read more
by Marie Jung Lucky for us, MedCity moved their annual patient engagement conference, ENGAGE, to San Diego from Washington, D.C., adding to our fall bumper crop of health related conferences. ENGAGE took place at the La Jolla Mariott Hotel on October 18th and 19th. It was a small, but very Read more
Two San Diego biotech companies, Vertex Pharmaceuticals, Inc. and Valeant Pharmaceuticals, ranked on Genetic Engineering & Biotechnology News‘ list of top 25 biotech companies based on their market cap as of September 6, 2016. Vertex ranked 13th on the list, with a market cap of $23.7 billion, and Valiant ranked 21, with a market cap of $10.49 billion. (Genetic Engineering & Biotechnology News)